QS vs. CRBU
QS (QuantumScape Corporation) and CRBU (Caribou Biosciences, Inc.) are both stocks. QS operates in Auto Parts (Consumer Cyclical), while CRBU operates in Biotechnology (Healthcare). Over the past 3 years, QS returned 1.35%/yr vs -27.35%/yr for CRBU. At a 0.44 correlation, their price movements are largely independent.
Performance
QS vs. CRBU - Performance Comparison
Loading charts...
Returns By Period
In the year-to-date period, QS achieves a -31.67% return, which is significantly lower than CRBU's 4.40% return.
QS
- 1D
- -4.04%
- 1M
- -13.17%
- YTD
- -31.67%
- 6M
- -36.31%
- 1Y
- 64.43%
- 3Y*
- 1.35%
- 5Y*
- -24.47%
- 10Y*
- —
CRBU
- 1D
- 0.00%
- 1M
- -20.95%
- YTD
- 4.40%
- 6M
- -3.49%
- 1Y
- 17.73%
- 3Y*
- -27.35%
- 5Y*
- —
- 10Y*
- —
QS vs. CRBU - Yearly Performance Comparison
| 2026 (YTD) | 2025 | 2024 | 2023 | 2022 | 2021 | |
|---|---|---|---|---|---|---|
QS QuantumScape Corporation | -31.67% | 100.77% | -25.32% | 22.57% | -74.45% | -5.25% |
CRBU Caribou Biosciences, Inc. | 4.40% | 0.00% | -72.25% | -8.76% | -58.38% | -14.50% |
Correlation
The correlation between QS and CRBU is 0.35, which is low. Their price movements are largely independent, making them effective diversification partners.
| Correlation | |
|---|---|
Correlation (1Y) Calculated over the trailing 1-year period | 0.35 |
Correlation (3Y) Calculated over the trailing 3-year period | 0.39 |
Correlation (All Time) Calculated using the full available price history since Jul 23, 2021 | 0.44 |
Fundamentals
QS:
$4.35B
CRBU:
$159.13M
QS:
-$0.72
CRBU:
-$1.41
QS:
3.92
CRBU:
1.56
QS:
$0.00
CRBU:
$8.81M
QS:
-$49.03M
CRBU:
$7.49M
QS:
-$378.92M
CRBU:
-$115.23M
Compare stocks, funds, or ETFs
Search for stocks, ETFs, and funds for a quick comparison or use the comparison tool for more options.
Return for Risk
QS vs. CRBU — Risk / Return Rank
QS
CRBU
QS vs. CRBU - Risk-Adjusted Trends Comparison
This table presents a comparison of risk-adjusted performance metrics for QuantumScape Corporation (QS) and Caribou Biosciences, Inc. (CRBU). Risk-adjusted metrics are performance indicators that assess an investment's returns in relation to its risk, enabling a more accurate comparison of different investment options.
Values are calculated on a 1-year rolling basis and updated daily. Risk-adjusted metrics are more stable over longer periods — use the period switch above to explore them.
| QS | CRBU | Difference | |
|---|---|---|---|
| Sharpe ratioReturn per unit of total volatility | +0.40 | ||
| Sortino ratioReturn per unit of downside risk | +0.79 | ||
| Omega ratioGain probability vs. loss probability | 1.20 | 1.11 | +0.09 |
| Calmar ratioReturn relative to maximum drawdown | 0.96 | 0.35 | +0.61 |
| Martin ratioReturn relative to average drawdown | 1.44 | 0.59 | +0.86 |
Loading charts...
Drawdowns
QS vs. CRBU - Drawdown Comparison
The maximum QS drawdown since its inception was -97.36%, roughly equal to the maximum CRBU drawdown of -97.58%. Use the drawdown chart below to compare losses from any high point for QS and CRBU.
Loading charts...
Drawdown Indicators
| QS | CRBU | Difference | |
|---|---|---|---|
Max DrawdownLargest peak-to-trough decline | -97.36% | -97.58% | +0.22% |
Max Drawdown (1Y)Largest decline over 1 year | -67.68% | -51.06% | -16.62% |
Max Drawdown (3Y)Largest decline over 3 years | -73.93% | -91.12% | +17.19% |
Max Drawdown (5Y)Largest decline over 5 years | -91.45% | — | — |
Current DrawdownCurrent decline from peak | -94.59% | -94.52% | -0.07% |
Average DrawdownAverage peak-to-trough decline | -85.56% | -79.41% | -6.15% |
Ulcer IndexDepth and duration of drawdowns from previous peaks | 44.78% | 30.25% | +14.53% |
Volatility
QS vs. CRBU - Volatility Comparison
QuantumScape Corporation (QS) has a higher volatility of 27.88% compared to Caribou Biosciences, Inc. (CRBU) at 22.28%. This indicates that QS's price experiences larger fluctuations and is considered to be riskier than CRBU based on this measure. The chart below showcases a comparison of their rolling one-month volatility.
Loading charts...
Volatility by Period
| QS | CRBU | Difference | |
|---|---|---|---|
Volatility (1M)Calculated over the trailing 1-month period | 27.88% | 22.28% | +5.60% |
Volatility (6M)Calculated over the trailing 6-month period | 50.47% | 49.92% | +0.55% |
Volatility (1Y)Calculated over the trailing 1-year period | 104.48% | 81.54% | +22.94% |
Volatility (5Y)Calculated over the trailing 5-year period, annualized | 86.16% | 86.59% | -0.43% |
Volatility (10Y)Calculated over the trailing 10-year period, annualized | 105.90% | 86.59% | +19.31% |
Dividends
QS vs. CRBU - Dividend Comparison
Neither QS nor CRBU has paid dividends to shareholders.
Financials
QS vs. CRBU - Financials Comparison
This section allows you to compare key financial metrics between QuantumScape Corporation and Caribou Biosciences, Inc.. You can select fields from income statements, balance sheets, and cash flow statements to easily visualize and compare the financial health of both companies.
Total Revenue: Total amount of money received from sales and other business activities
Frequently Asked Questions
QS and CRBU have a correlation of 0.35, meaning they provide meaningful diversification benefit when combined. Depending on your allocation goals, holding both could reduce overall portfolio risk.
QS has higher volatility (27.88%) compared to CRBU (22.28%). In terms of maximum drawdown, QS dropped -97.36% vs CRBU's -97.58%.
QS currently has the higher Sharpe Ratio (0.62 vs 0.22), meaning it's delivered slightly more return per unit of risk over the trailing 12 months. However, this ranking shifts over time - use the Risk/Return Score above for a more comprehensive view that combines Sharpe, Sortino, and other measures used by quantitative funds.
Find the right allocation for QS and CRBU
Add both to a portfolio and optimize allocations for your target — whether that's maximizing returns, minimizing drawdowns, or balancing risk across holdings.
Open Portfolio Optimizer